Nj State Employees Deferred Compensation Plan Exact Sciences Corp Transaction History

Nj State Employees Deferred Compensation Plan

$824 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 02, 2018	SELL	$37.84 - $69.96 $189,200 - $349,799	-5,000 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$39.82 - $57.53 $199,100 - $287,650	5,000 New	5,000 $202,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

Vanguard Group Inc Valley Forge, PA

17.8M
Shares

$1.06 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

15.8M
Shares

$941 Million
0.17% of portfolio
Wellington Management Group LLP Boston, MA

14.3M
Shares

$851 Million
0.18% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$717 Million
0.01% of portfolio
State Street Corp Boston, MA

6.68M
Shares

$397 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.5B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nj State Employees Deferred Compensation Plan, based on Form 13F filings with the SEC.

News

Stay updated on Nj State Employees Deferred Compensation Plan with notifications on news.

Account